JAJ International
JAJ International is a worldwide leading company in the rapid one-step diagnostic industry, dedicated to developing, manufacturing, and marketing innovative rapid diagnostic test kits for various health conditions including infectious diseases, cancer, cardiac health, and drug abuse detection. The company emphasizes speed, accuracy, and cost-effectiveness in diagnostics, with a strong commitment to social responsibility and regulatory standards. They are actively involved in research and development of new diagnostic solutions, including tests for COVID-19, Zika, Tuberculosis, and more, aiming to provide early detection and improve health outcomes globally.
Industries
Nr. of Employees
small (1-50)
JAJ International
San Diego, California, United States, North America
Products
Rapid lateral-flow antibody/antigen tests (one-step)
Point-of-care lateral flow immunoassays for detection of antibodies or antigens from fingerprick blood, serum or plasma with short read times.
COVID-19 IgG/IgM antibody rapid test (prototype)
Prototype IgG/IgM antibody lateral flow test for SARS-CoV-2 using 10 µL fingerprick blood and a ~15-minute read; regulatory submissions (EUA) and CE registration noted.
Multiplex disease panels (e.g., mosquito 5-in-1)
Multi-analyte rapid panels combining several targets (examples: dengue IgG/IgM, NS1, malaria, chikungunya) in a single cassette.
Drug-of-abuse rapid tests and combination cassettes
Rapid urine and saliva tests for a wide panel of drugs of abuse, including multi-analyte combination cassettes up to 12 tests.
ELISA and CLIA kit product lines
Cataloged ELISA and CLIA kits for laboratory diagnostic applications across multiple indications.
Quantitative point-of-care reader devices
Digital readers intended to provide quantitative outputs for rapid diagnostic assays at point-of-care.
Rapid lateral-flow antibody/antigen tests (one-step)
Point-of-care lateral flow immunoassays for detection of antibodies or antigens from fingerprick blood, serum or plasma with short read times.
COVID-19 IgG/IgM antibody rapid test (prototype)
Prototype IgG/IgM antibody lateral flow test for SARS-CoV-2 using 10 µL fingerprick blood and a ~15-minute read; regulatory submissions (EUA) and CE registration noted.
Multiplex disease panels (e.g., mosquito 5-in-1)
Multi-analyte rapid panels combining several targets (examples: dengue IgG/IgM, NS1, malaria, chikungunya) in a single cassette.
Drug-of-abuse rapid tests and combination cassettes
Rapid urine and saliva tests for a wide panel of drugs of abuse, including multi-analyte combination cassettes up to 12 tests.
ELISA and CLIA kit product lines
Cataloged ELISA and CLIA kits for laboratory diagnostic applications across multiple indications.
Quantitative point-of-care reader devices
Digital readers intended to provide quantitative outputs for rapid diagnostic assays at point-of-care.
Services
OEM and private-label manufacturing
Custom production, private labeling and OEM supply of diagnostic tests according to client specifications.
Regulatory support for diagnostic products
Assistance with regulatory submissions and provision of related certificates for export and foreign government requirements.
Clinical evaluation partnerships
Collaboration with public health entities and organizations to conduct clinical evaluations and collect clinical data for prototype diagnostics.
Sample provisioning and distributor support
Provision of limited free samples for rapid tests and support for distributor onboarding and territory negotiations.
OEM and private-label manufacturing
Custom production, private labeling and OEM supply of diagnostic tests according to client specifications.
Regulatory support for diagnostic products
Assistance with regulatory submissions and provision of related certificates for export and foreign government requirements.
Clinical evaluation partnerships
Collaboration with public health entities and organizations to conduct clinical evaluations and collect clinical data for prototype diagnostics.
Sample provisioning and distributor support
Provision of limited free samples for rapid tests and support for distributor onboarding and territory negotiations.
Expertise Areas
- Rapid diagnostic test development
- Lateral flow immunoassays
- ELISA and CLIA assay development
- Point-of-care quantitative readers
Key Technologies
- Lateral flow immunochromatography
- Enzyme-linked immunosorbent assay (ELISA)
- Chemiluminescence immunoassay (CLIA)
- Antigen/antibody immunoassays